Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

SYNTAX score: an independent predictor of long-term cardiac mortality in patients with acute ST-elevation myocardial infarction.

Yang CH, Hsieh MJ, Chen CC, Chang SH, Wang CY, Lee CH, Hsieh IC.

Coron Artery Dis. 2012 Nov;23(7):445-9.

PMID:
22968215
3.

Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.

Brkovic V, Dobric M, Beleslin B, Giga V, Vukcevic V, Stojkovic S, Stankovic G, Nedeljkovic MA, Orlic D, Tomasevic M, Stepanovic J, Ostojic M.

Int J Cardiovasc Imaging. 2013 Aug;29(6):1215-28. doi: 10.1007/s10554-013-0202-1.

PMID:
23443340
4.

The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.

Chen SL, Han YL, Zhang YJ, Ye F, Liu HW, Zhang JJ, Xu B, Jiang TM, Zhou YJ, Lv SZ.

JACC Cardiovasc Interv. 2013 Dec;6(12):1233-41. doi: 10.1016/j.jcin.2013.08.006.

5.

Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.

Chen SL, Chen JP, Mintz G, Xu B, Kan J, Ye F, Zhang J, Sun X, Xu Y, Jiang Q, Zhang A, Stone GW.

JACC Cardiovasc Interv. 2010 Jun;3(6):632-41. doi: 10.1016/j.jcin.2010.04.006.

6.

Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.

Piccolo R, Pilgrim T, Heg D, Franzone A, Rat-Wirtzler J, Räber L, Silber S, Serruys PW, Jüni P, Windecker S.

JACC Cardiovasc Interv. 2015 Nov;8(13):1657-66. doi: 10.1016/j.jcin.2015.08.013.

7.

Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization.

Kim YH, Park DW, Kim WJ, Lee JY, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Park SJ.

JACC Cardiovasc Interv. 2010 Jun;3(6):612-23. doi: 10.1016/j.jcin.2010.04.004.

8.

Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.

Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A; ISAR-LEFT MAIN Study Investigators..

JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013.

9.

Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).

Holmvang L, Kelbæk H, Kaltoft A, Thuesen L, Lassen JF, Clemmensen P, Kløvgaard L, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Tilsted HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Helqvist S.

JACC Cardiovasc Interv. 2013 Jun;6(6):548-53. doi: 10.1016/j.jcin.2012.12.129.

10.

Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center.

Shammas NW, Shammas GA, Jerin M, Sharis P.

Vasc Health Risk Manag. 2014 Sep 9;10:563-7. doi: 10.2147/VHRM.S64696.

11.

Initial SYNTAX score predicts major adverse cardiac events after primary percutaneous coronary intervention.

Brown AJ, McCormick LM, Gajendragadkar PR, Hoole SP, West NE.

Angiology. 2014 May;65(5):408-12. doi: 10.1177/0003319713483542.

PMID:
23574751
12.

Long-term clinical results following stenting of the left main stem: insights from RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.

Onuma Y, Girasis C, Piazza N, Garcia-Garcia HM, Kukreja N, Garg S, Eindhoven J, Cheng JM, Valgimigli M, van Domburg R, Serruys PW; Interventional Cardiologists at Thoraxcenter 2000-2005..

JACC Cardiovasc Interv. 2010 Jun;3(6):584-94. doi: 10.1016/j.jcin.2010.03.017.

13.

Comparison of the predictive value of EuroSCORE, SYNTAX score, and clinical SYNTAX score for outcomes of patients undergoing percutaneous coronary intervention for unprotected left main coronary artery disease.

Jou YL, Lu TM, Chen YH, Sung SH, Wang KL, Huang SS, Lin WT, Chan WL, Lin SJ.

Catheter Cardiovasc Interv. 2012 Aug 1;80(2):222-30. doi: 10.1002/ccd.23450.

PMID:
22334399
14.

The value of the Clinical SYNTAX Score in predicting long-term prognosis in patients with ST-segment elevation myocardial infarction who have undergone primary percutaneous coronary intervention.

Cetinkal G, Dogan SM, Kocas C, Abaci O, Arslan S, Balaban Kocas B, Karaca OS, Buyuk A, Firidin N, Yildiz A.

Coron Artery Dis. 2016 Mar;27(2):135-42. doi: 10.1097/MCA.0000000000000332.

PMID:
26720108
15.

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).

Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Scalone G, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-97. doi: 10.1016/j.jcin.2014.10.005. Erratum in: JACC Cardiovasc Interv. 2015 Mar;8(3):503.

16.

SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy.

Yadav M, Généreux P, Palmerini T, Caixeta A, Madhavan MV, Xu K, Brener SJ, Mehran R, Stone GW.

Catheter Cardiovasc Interv. 2015 Jan 1;85(1):1-10. doi: 10.1002/ccd.25396.

PMID:
24408084
17.

Long-term effectiveness and safety of triple versus dual antiplatelet therapy after percutaneous coronary intervention for unprotected left main coronary artery disease.

Lee HJ, Yu CW, Hwang HK, Choi RK, Park JS, Li H, Ro YM.

Coron Artery Dis. 2013 Nov;24(7):542-8. doi: 10.1097/MCA.0b013e328363abbd.

PMID:
23994880
18.

Gender differences in long-term outcome after primary percutaneous intervention for ST-segment elevation myocardial infarction.

Wijnbergen I, Tijssen J, van 't Veer M, Michels R, Pijls NH.

Catheter Cardiovasc Interv. 2013 Sep 1;82(3):379-84. doi: 10.1002/ccd.24800.

PMID:
23553888
19.

Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.

Palmerini T, Calabrò P, Piscione F, De Servi S, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Barozzi C, Tomasi L, Della Riva D, Mariani A, Taglieri N, Reggiani LB, Bianchi R, De Rosa R, Mariani M, Podda G, Généreux P, Stone GW, Angiolillo DJ.

JACC Cardiovasc Interv. 2014 Oct;7(10):1117-27. doi: 10.1016/j.jcin.2014.04.020.

20.

2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.

Gyöngyösi M, Christ G, Lang I, Kreiner G, Sochor H, Probst P, Neunteufl T, Badr-Eslam R, Winkler S, Nyolczas N, Posa A, Leisch F, Karnik R, Siostrzonek P, Harb S, Heigert M, Zenker G, Benzer W, Bonner G, Kaider A, Glogar D; AUTAX Investigators..

JACC Cardiovasc Interv. 2009 Aug;2(8):718-27. doi: 10.1016/j.jcin.2009.05.019.

Items per page

Supplemental Content

Support Center